PLGA Market Set to Expand at 16.4% CAGR, Hitting USD USD 633.97 Million by 2034

PLGA Market Overview:

Global PLGA Market size and share is currently valued at USD 138.73 million in 2024 and is anticipated to generate an estimated revenue of USD 633.97 million by 2034, according to the latest study by Polaris Market Research. Besides, the report notes that the market exhibits a robust 16.4% Compound Annual Growth Rate (CAGR) over the forecasted timeframe, 2025 – 2034

Key Market Drivers:

  • Government Initiatives and Regulations: Supportive government policies and regulations promoting the use of biodegradable polymers have significantly influenced the PLGA market. For instance, countries like Germany and France have implemented stringent regulations favoring eco-friendly materials in packaging, boosting PLGA adoption.
  • Growing Demand for Drug Delivery Applications: The pharmaceutical and biotech sectors’ increasing demand for PLGA, particularly in drug encapsulation and controlled release applications, is a key factor fueling market expansion.

Download Free Sample PDF Copy of the Report:

https://www.polarismarketresearch.com/industry-analysis/plga-market/request-for-sample

Key Companies in PLGA Market:

  • Akina, Inc.
  • Ashland
  • Bezwada Biomedical, LLC.
  • CD Bioparticles
  • Corbion NV
  • Evonik
  • Jinan Digang Bioengineering Co., Ltd.
  • Merck
  • Mitsui Chemicals
  • Nomisma Healthcare Pvt. Ltd

PLGA Market – Research Scope

The research scope for the PLGA Market primarily focuses on its application in biomedicine, particularly in drug delivery systems, tissue engineering, and biodegradable medical implants. It explores advancements in production techniques, environmental benefits as a biodegradable polymer, and regional differences in adoption driven by regulatory frameworks. Additionally, studies delve into the customization of PLGA properties through co-polymer ratios and molecular weight variations to enhance performance in targeted medical applications.

PLGA Market Segmentation:

The PLGA Market is segmented based on application, type, and region. By application, it includes drug delivery systems, surgical sutures, tissue engineering, and others. By type, the market is categorized into amorphous PLGA and semi-crystalline PLGA, differentiated by molecular composition and degradation profiles. Regionally, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World, with North America leading due to extensive healthcare R&D and regulatory support for biodegradable materials.

PLGA Market, Grade Outlook (Revenue, USD Million, 2020-2034)

  • Extrusion
  • Injection Molding
  • Others

PLGA Market, Composition Outlook (Revenue, USD Million, 2020-2034)

  • PLGA 50:50
  • PLGA 55:45
  • PLGA 65:35
  • PLGA 75:25
  • PLGA 85:15
  • PLGA 12:88
  • PLGA 10:90
  • Others

PLGA Market, Application Outlook (Revenue, USD Million, 2020-2034)

  • Drug Delivery
  • Medical Implants
  • Tissue Engineering
  • Fracture Fixation
  • Gene Delivery
  • Surgical Sutures
  • Packaging
  • Disposable Cutlery
  • Textile
  • Agricultural Films
  • Others

PLGA Market, Type Outlook (Revenue, USD Million, 2020-2034)

  • Dayglow Pigments
  • Phosphorescent Pigments
  • Other

PLGA Market, End Use Outlook (Revenue, USD Million, 2020-2034)

  • Healthcare
  • Biotech firms
  • Medical Institutions
  • Packaging
  • Others

PLGA Industry Developments:

  • December 2020: Evonik completed the acquisition of LACTEL Absorbable Polymers from DURECT Corporation, enhancing its biodegradable polymer portfolio and reinforcing its position in the functional excipients and biomaterials market.
  • June 2023: Avantium N.V. and SCG announced a collaboration to develop CO₂-based polymers utilizing Avantium’s Volta Technology platform. The partnership aims to scale production to a pilot level, focusing on creating polylactic-co-glycolic acid (PLGA), a recyclable, home-compostable, and marine-degradable polyester with exceptional oxygen and moisture barrier properties.
  • March 2023: Evonik partnered with BellaSeno to advance 3D-printed bone scaffolds using Evonik’s Resomer polymers for addressing large and complex bone defects. This builds on their initial collaboration in 2019, which concentrated on scaffolds for chest wall and breast reconstruction.

The PLGA market report offers an in-depth analysis of market dynamics, including trends, sizes, patterns, and growth factors. It highlights critical developments and emerging trends to help stakeholders refine their strategies and strengthen market positioning. The report concludes with a detailed summary of key findings and the research methodologies employed. This comprehensive analysis serves as a valuable resource for businesses, investors, and stakeholders, enabling them to make informed decisions and drive sustainable growth.